Cholestasis of Parenteral Nutrition

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Cholestasis of Parenteral Nutrition trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingPhase 4

NCT06049680

Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients

Evaluate the risk of developing EFAD and/or PNAC in adult and pediatric patients 1 month of age and older, who are anticipated to need 8 weeks or longer of pare…

United States100 participantsStarted 2024-10-28

Treatment: SMOFlipid® (lipid injectable emulsion)

RecruitingNot Applicable

NCT06274788

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Ome…

This study will demonstrate safety in pediatric patients with Parenteral Nutrition-Associated Cholestasis treated with Omegaven®, which is indicated as a source…

United States40 participantsStarted 2024-12-15

Treatment: Omegaven® (fish oil triglycerides) Injectable Emulsion

All recent trials (57 shown)

CompletedPhase 3

NCT01194063

Use of Omegaven Fish Oil Emulsion for Parenteral Nutrition Associated Liver Disease in Infants and Children

Use of a fish oil emulsion to decrease liver disease due to long term intravenous nutrition.

United States36 participantsStarted 2010-10-20

Treatment: Omega-3 fish oil lipid emulsion

CompletedNot Applicable

NCT01072721

Non Invasive Study of the Hepatic Fibrosis in Paediatrics by the Method of Study of Pediatric Hepatic Fibrosis

Early diagnosis of liver fibrosis is useful for the follow-up and treatment of chronic liver disease. At present, the unique validated method to evaluate the li…

France264 participantsStarted 2010-01-19

Treatment: Elastometry

Cholestasis of Parenteral Nutrition

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Ome…

All recent trials (57 shown)

Use of Omegaven Fish Oil Emulsion for Parenteral Nutrition Associated Liver Disease in Infants and Children

Non Invasive Study of the Hepatic Fibrosis in Paediatrics by the Method of Study of Pediatric Hepatic Fibrosis

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Ome…

All recent trials (57 shown)

Use of Omegaven Fish Oil Emulsion for Parenteral Nutrition Associated Liver Disease in Infants and Children

Non Invasive Study of the Hepatic Fibrosis in Paediatrics by the Method of Study of Pediatric Hepatic Fibrosis

Expanded Access of Omegaven IV Fat Emulsion to Infants and Children With PNALD

SMOF Lipid for Children With Parenteral Nutrition Induced Liver Injury

Comparison of Smoflipid to Soy-based Lipid Reduction for Cholestasis Prevention in Surgical Neonates

Cholestasis Reversal: Efficacy of IV Fish Oil

Intravenous Fat Emulsion Comprised of Fish Oil in the Treatment of Parenteral Nutrition Induced Liver Injury in Infants

Parenteral Nutrition Cycling for Prevention of Cholestatic Syndrome in Newborn

Compassionate Use of Omegaven® for the Treatment of Intestinal Failure Associated Liver Disease in Children

Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-…

Evaluation of Omegaven™ Parenteral Nutrition in Patients With Total Parenteral Nutrition (TPN)-Induced Cholestasis

Prevalence of Liver Disease in Patients Dependent on Parenteral Nutrition

Omegaven® in the Treatment of Parenteral Nutrition (PN) Induced Liver Injury

Safety of Omegaven in Pediatric Patients With Parenteral Nutrition-Associated Cholestasis (PNAC)

Ursodeoxycholic Acid Prevents Total Parenteral Nutrition Cholestasis

Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-…

Compassionate Use of an Intravenous Fish Oil Emulsion in the Treatment of Liver Injury in Infants

Elemental Formula in Neonates Post Small Bowel Resection: Improved Weaning From Total Parenteral Nutrition?

Compassionate Use of an Intravenous Fish Oil Emulsion in Infants With Cholestasis

Use of Omega 3 Oil Emulsion for Parenteral Nutrition Associated Cholestasis